Article
Druggable targets and therapeutic development for COVID-19
5 Oct 2022
Abstract excerpt
Coronavirus disease (COVID-19), which is caused by SARS-CoV-2, is the biggest challenge to the global public health and economy in recent years. Until now, only limited therapeutic regimens have been available for COVID-19 patients, sparking unprecedented efforts to study coronavirus biology. The genome of SARS-CoV-2 encodes 16 non-structural, four structural, and nine accessory proteins, which mediate the viral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
